Thermo Fisher Scientific TMO Payment for (Proceeds from) Other Investing Activity
Payment for (Proceeds from) Other Investing Activity at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromOtherInvestingActivities.
The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's payment for (proceeds from) other investing activity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Thermo Fisher Scientific's payment for (proceeds from) other investing activity?
- Thermo Fisher Scientific (TMO) reported payment for (proceeds from) other investing activity of $55M in Q1 2026.
- How has Thermo Fisher Scientific's payment for (proceeds from) other investing activity changed year-over-year?
- Thermo Fisher Scientific's payment for (proceeds from) other investing activity increased by 5400.0% year-over-year, from $1M to $55M.
- What is the long-term trend for Thermo Fisher Scientific's payment for (proceeds from) other investing activity?
- Over 2 years (2021 to 2025), Thermo Fisher Scientific's payment for (proceeds from) other investing activity has grown at a -29.3% compound annual growth rate (CAGR), from $42M to -$21M.
- What does payment for (proceeds from) other investing activity mean?
- Net cash flows resulting from investing activities that do not fall under standard categories like securities or loans. This may include investments in joint ventures, real estate, or other non-financial assets. It serves as a catch-all for miscellaneous capital deployment or divestment activities.